Neoadjuvant Combination Therapy with Tyrosine Kinase and Immune Checkpoint Inhibitors in Anaplastic Thyroid Cancer: A Single-Center, Real-World Experience

Annals of Surgical Oncology 2026

View at publisher
Authors: Yuntao Song, Yabing Zhang, Jiaxin Wang, Kuangyu Fei, Guohui Xu, Tianxiao Wang, Bin Zhang
DOI: 10.1245/s10434-026-19139-6
Cited by: 1
References: 21

Fields of Study & Subjects

Thyroid Cancer Diagnosis and Treatment Multiple and Secondary Primary Cancers Renal cell carcinoma treatment

Publication details

Journal / source
Annals of Surgical Oncology
Publisher
Springer Science and Business Media LLC
Volume
33
Issue
7
Pages
5950–5957
Publication date
3 April 2026
Language
EN